Gadolinium neutron capture in glioblastoma multiforme cells

References

• Alpen E L. Radiation biophysics. Academic Press, San Diego, CA 1998; 92–96
   Google Scholar
• Bewley D K, Fowler J L, Morgan R L. VII. Experiments on the skin of pigs with fast neutrons and 8 MV X rays including some effects of dose fractionation. British Journal of Radiology 1963; 36: 107–115
   Google Scholar
• Bernard E J, Mitchell J B, Deen D, Cardell M, Rosenthal D I, Brown J M. Re-evaluating gadolinium (III) texaphryn as a radiosensitizing agent. Cancer Research 2000; 60: 86–91
   PubMedGoogle Scholar
• Britten R A, Peters L A, Murray D. Biological factors influencing the RBE of neutrons: Implications for their past, present and future use in radiotherapy. Radiation Research 2001; 156: 125–135
   PubMedGoogle Scholar
• Britten R A, Warenius H M, Parkins C, Peacock J H. The inherent cellular sensitivity to 62.5 MeV(p-> Be+) neutrons of human cells differing in photon sensitivity. International Journal of Radiation Biology 1992; 61: 805–812
   PubMed Web of Science ®Google Scholar
• Catterall M, Bewley D. Fast neutrons in the treatment of cancer. Academic Press, London 1979; 394
   Google Scholar
• Catterall M, Bloom H JG, Ash D V, Walsh L, Richardson A, Uttley D, Gowing N, Lewis P, Bhaucer B. Fast neutrons compared with megavoltage X-rays in the treatment of patients with supratentorial glioblastoma: A controlled pilot study. International Journal of Radiation, Oncology, Biology and Physics 1980; 6: 261–266
   PubMed Web of Science ®Google Scholar
• Chapman D. Biophysical models of mammalian cell inactivation by radiation. Radiation biology in cancer research, R E Meyn, H R Withers. Raven Press, New York 1980; 21–32
   Google Scholar
• Cole A. Absorption of 20-eV to 50,000-eV electron beams in air and plastic. Radiation Research 1969; 38: 7–33
   PubMed Web of Science ®Google Scholar
• DeStasio G, Casalbore P, Pallini R, Gilbert B, Sanita F, Ciotti M T, Rosi G, Festinesi A, Larocca L M, Rinelli A, Perret D, Mogk D W, Perfetti P, Mehta M P, Mercanti D. Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy. Cancer Research 2001; 61: 4272–4277
   PubMedGoogle Scholar
• DeStasio G, Rajesh D, Casalbore P, Daniels M J, Erhardt R J, Frazer B H, Wiese L M, Richter K L, Sonderegger B R, Bilgert B, Schaub S, Cannara R J, Crawford J F, Gilles M K, Tyliszczak T, Folwer J F, Larocca L M, Howard S P, Mercanti D, Mehta M P, Pallini R. Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?. Neurological Research 2005; 27: 387–398
   PubMedGoogle Scholar
• Elkind M M. Repair processes in radiation biology. Radiation Research 1984; 100: 425–449
   PubMed Web of Science ®Google Scholar
• Elkind M M, Whitmore G F. The radiobiology of cultured mammalian cells. Gordon and Breach, New York 1967; 60
   Google Scholar
• Field S B. An historical survey of radiobiology and radiotherapy with fast neutrons. Current Topics in Radiation Research Quarterly 1976; 11: 1–86
   PubMedGoogle Scholar
• Franken N AP, Bergs J WJ, Kok T T, Kuperus R RN, Stecher-Rasmussen F, Haveban J, Van Bree C, Stalpers L JA. Gadolinium enhances the sensitivity of SW-1573 cells for thermal neutron irradiation. Oncology Reports 2006; 15: 715–720
   PubMedGoogle Scholar
• Goorley T, Nikjoo H. electron and photon spectra for three gadolinium-based cancer therapy approaches. Radiation Research 2000; 154: 556–563
   PubMed Web of Science ®Google Scholar
• Gragg R L, Humphrey R M, Meyn R E. The response of Chinese Hamster Ovary cells to fast neutron radiotherapy beams. II. Sublethal and potentially lethal damage recovery capabilities. Radiation Research 1977; 71: 461–470
   PubMed Web of Science ®Google Scholar
• Gragg R L, Humphrey R M, Thames H D, Meyn R E. The response of Chinese Hamster Ovary cells to fast neutron radiotherapy beams. III. Variation in relative biological effectiveness with position in cell cycle. Radiation Research 1978; 76: 283–291
   PubMed Web of Science ®Google Scholar
• Gray L H, Conger A D, Ebert M, Hornsey S, Scott O CA. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. British Journal of Radiology 1953; 26: 638–648
   PubMed Web of Science ®Google Scholar
• Gueulette J, Beauduin M, Gregoire V, Vynckier S, DeCoster B M, Octave-Prignot M, Wambersie A, Strijkmans K, DeSchrijver A, El-Akkad S, Bohm L, Slabbert J P, Jones D T, Maughan R, Onoda J, Yudelev M, Porter A T, Powers W E, Sabattier R, Breteau N, Courdi A, Brassart N, Chauvel P. RBE variation between fast neutron beams as a function of energy. Intercomparison involving 7 neutron therapy facilities. Bulletin of Cancer Radiotherapy 1996; 83: 55s–63
   Google Scholar
• Gupta N, Hu L J, Deen D F. Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation. International Journal of Radiation Oncology, Biology and Physics 1997; 37: 885–895
   PubMed Web of Science ®Google Scholar
• Hall E J. Radiobiology for the radiologist3rd ed. J.B. Lippincott Co, Philadelphia, PA 1998; 12–15
   Google Scholar
• ICRU Report 26. Neutron dosimetry for biology and medicine. International Commission on Radiation Units and Measurements, Washington, DC 1977
   Google Scholar
• Kataoka Y, Murley J S, Patel R, Grdina D J. Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines. International Journal of Radiation Biology 2000; 76: 633–639
   PubMedGoogle Scholar
• Ke L D, Shi Y-X, Im S-A, Chen X, Ung W K. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast factor production to antiogeneisis and tumorigenesis in human glioma cell lines. Clinical Cancer Research 2000; 6: 2567–2572
   Google Scholar
• Lang F F, Yung W KA, Raju U, Libunao F, Terry N HA, Tofilon P J. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene. Journal of Neurosurgery 1998; 89: 125–132
   PubMed Web of Science ®Google Scholar
• Martin R F, D'Cunha G, Pardee M, Allen B J. Induction of double strand breaks following neutron capture by DNA bound 157Gd. International Journal of Radiation Biology 1988; 54: 205–208
   PubMed Web of Science ®Google Scholar
• Millar B C, Fielden E M, Millar J L. Interpretation of survival-curve data for Chinese hamster cells, line V-79 using the multi-target, multi-target with initial slope, and α, β equations. International Journal of Radiation Biology 1978; 33: 599–603
   Web of Science ®Google Scholar
• Newton D E. Chemical elements. Nuclear data for neutron therapy: Status and future needs, L W Baker. Gale, Detroit 1999, Technical Report IAEA-TECDOC-992. International Atomic Energy Agency, Vienna, Austria, December, 1997
   Google Scholar
• Peak M J, Wang L, Hill C K, Peak J G. Comparison of repair of DNA double strand breaks caused by neutron or gamma radiation in cultured human cells. International Journal of Radiation Biology 1991; 60: 891–898
   PubMed Web of Science ®Google Scholar
• Ponten J, Westermark B. Properties of human malignant glioma cells in vitro. Medical Biology 1978; 56: 184–193
   PubMedGoogle Scholar
• Saroja K R, Mansell J, Hendrickson F R, Cohen L, Lennox A. Failure of accelerated neutron therapy to control high grade astrocytomas. International Journal of Radiation Oncology, Biology and Physics 1989; 27: 1295–1297
   Google Scholar
• Stone R S. Neutron therapy and specific ionization. American Journal of Roentgenology 1948; 36: 107–115
   Google Scholar
• Stupp R, Mason W P, van den Bent M J, Weller M, Fisher B, Taphoorn M JB, Belander K, Brandes A A, et al. Radiotherapy plus concomitant and adjuvant temozolomide for Glioblastoma. New England Journal of Medicine 2005; 352: 987–996
   PubMed Web of Science ®Google Scholar
• Sweezy J, Hertel N, Lennox A. Filter, collimator and moderating material to achieve boron neutron capture enhanced fast neutron therapy. Radiation Protection Dosimetry 2005; 116: 470–474
   PubMedGoogle Scholar
• Van Meir E G, Kikuchi T, Taka M, Li H, Diserens A-C, Wojcik B E, Huang H-J, Friedmann T, de Tribolet N, Cavenee W K. Analysis of the p53 gene and its expression in human Glioblastoma cells. Cancer Research 1994; 54: 649–652
   PubMed Web of Science ®Google Scholar
• Walicka M A, Ding Y, Roy A M, Harapanhalli R S, Adelstein S J. Cytotoxicity of [125I]iodoHoechst 33342: Contribution of scavengeable effects. International Journal of Radiation Biology 1999; 75: 1579–1587
   PubMed Web of Science ®Google Scholar
• Wang Z. Design of a boron neutron capture enhanced fast neutron therapy assembly. 2006, PhD Dissertation. G.W. Woodruff School of Mechanical Engineering. Georgia Institute of Technology
   Google Scholar
• Waterman F M, Kuchnir F T, Skaggs L S, Bewley D K, Page B C, Attix F H. The use of 10B to enhance the tumor dose in fast neutron therapy. Physics Medicine Biology 1978; 23: 592–602
   PubMed Web of Science ®Google Scholar
• Yasui L S. γH2AX foci induced by γ rays and 125IdU decay. International Journal of Radiation Biology 2004; 80: 895–903
   PubMed Web of Science ®Google Scholar
• Yasui L S, Hofer K G. Role of mitochondrial DNA in cell death induced by 125I decay. International Journal of Radiation Biology 1986; 49: 601–610
   Web of Science ®Google Scholar
• Yasui L S, Hofer K G, Warters R L. Inhomogeneity of the nucleus to 125IUdR cytotoxicity. Radiation Research 1985; 102: 106–118
   PubMed Web of Science ®Google Scholar
• Yasui L S, Hughes A, DeSombre E R. Relative biological effectiveness of accumulated 125IUdR and 125I-estrogen decays in estrogen receptor expressing human breast cancer cells. Radiation Research 2001; 155: 328–334
   PubMed Web of Science ®Google Scholar